Stephan Meding
Thermo Fisher Scientific (Germany)(DE)
Publications by Year
Research Areas
Advanced Proteomics Techniques and Applications, Mass Spectrometry Techniques and Applications, Molecular Biology Techniques and Applications, Metabolomics and Mass Spectrometry Studies, Thyroid Cancer Diagnosis and Treatment
Most-Cited Works
- → MALDI Imaging Identifies Prognostic Seven-Protein Signature of Novel Tissue Markers in Intestinal-Type Gastric Cancer(2011)137 cited
- → Tumor Classification of Six Common Cancer Types Based on Proteomic Profiling by MALDI Imaging(2012)136 cited
- → Tissue‐based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer(2012)135 cited
- → MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma(2012)105 cited
- → Comprehensive Identification of Proteins from MALDI Imaging(2013)82 cited
- → Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria(2013)79 cited
- → Classification of HER2/neu Status in Gastric Cancer Using a Breast-Cancer Derived Proteome Classifier(2010)78 cited
- → Proteomic Analysis of PAXgene-Fixed Tissues(2010)70 cited
- → Matrix‐assisted laser desorption/ionization imaging protocol for in situ characterization of tryptic peptide identity and distribution in formalin‐fixed tissue(2013)65 cited
- → S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging(2011)62 cited